Cardiac Assist Devices And Equipment Market Report 2026

Cardiac Assist Devices And Equipment Market Overview

• Cardiac Assist Devices And Equipment market size has reached to $2.35 billion in 2025 • Expected to grow to $3.76 billion in 2030 at a compound annual growth rate (CAGR) of 10.4% • Growth Driver: A Rise In The Prevalence Of Cardiovascular Diseases (CVD) In Cardiac Assist Devices And Equipment Market • Market Trend: Revolutionizing Heart Failure Care With Cardiomems Hf System • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Cardiac Assist Devices And Equipment Market?

Cardiac assist devices and equipment are electromechanical devices that assist in pumping blood from the heart to the rest of the body. These devices are used either to partially or completely replace the function of a failing heart. They help improve blood circulation, reduce the workload on the heart, and can even provide life-saving assistance in critical situations. The main types of cardiac assist devices and equipment are ventricular assist devices, intra-aortic balloon pumps, and the total artificial heart. Ventricular assist devices are electromechanical devices used to help with cardiac circulation. The various types of modalities are transcutaneous and implantable. These are used in hospital pharmacies, ambulatory surgical centers, and emergency services.

What Is The Cardiac Assist Devices And Equipment Market Growth Forecast?

The cardiac assist devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $3.76 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for destination therapy devices, rising adoption of remote monitoring-enabled assist systems, expansion of bridge-to-transplant applications, growing investments in next-generation cardiac devices, advancements in biocompatible materials and device miniaturization. Major trends in the forecast period include increasing adoption of implantable assist devices, rising use of minimally invasive cardiac support systems, growing integration of remote patient monitoring, expansion of pediatric and specialized cardiac devices, enhanced focus on long-term device reliability.

Global Cardiac Assist Devices And Equipment Market Segmentation

1) By Type: Ventricular Assist Devices (LVAD), Intra-Aotic Baloon Pumps, Total Artificial Heart 2) By Modality: Transcutaneous, Implantable 3) By Application: Hospitals And Cardiac Care Centers, Ambulatory Surgical Centres, Emergency Services Subsegments: 1) By Ventricular Assist Devices (LVAD): Implantable LVADs, Externally Powered LVADs, Pediatric LVADs, Other LVADs 2) By Intra-Aortic Balloon Pumps: Disposable Intra-Aortic Balloon Pumps, Reusable Intra-Aortic Balloon Pumps 3) By Total Artificial Heart: Pneumatically Powered Total Artificial Heart, Electrically Powered Total Artificial Heart, Other Total Artificial Heart Types

What Is The Driver Of The Cardiac Assist Devices And Equipment Market?

A rise in the prevalence of cardiovascular diseases (CVD) increases the demand for cardiac assist devices and equipment in developed and developing economies. The increasing need for diagnosis, monitoring, early-stage treatment, and prevention of these life-threatening diseases, increases the demand for cardiac assist devices. For instance, according to the American Heart Association, a US-based nonprofit organization, by 2035, 45.1% of the US population is s to have some form of CVD. Total costs of CVD are expected to reach $1.1 trillion in 2035, with direct medical costs projected to reach $748.7 billion and indirect costs estimated to reach $368 billion. Therefore, a rise in the prevalence of cardiovascular diseases is driving the growth of the cardiac assist devices and equipment industry.

Key Players In The Global Cardiac Assist Devices And Equipment Market

Major companies operating in the cardiac assist devices and equipment market are Abbott Laboratories, Berlin Heart GmbH, Abiomed Inc., Bivacor Pvt. Ltd., Calon Cardio-Technology Ltd., Cardiobridge GmbH, Cardiac Assist Inc., Braile Biomedica Ltd., Circulite Inc., Evaheart Inc., FineHeart Sarl, Getinge AB, Jarvik Heart Inc., Medtronic plc, OregonHeart, MitiHeart Corporation, Procyrion Inc., Scandinavian Real Heart AB, Syncardia Systems LLC, HeartWare International Inc., Cardiac Power Innovations, Cardionomic Inc., Carmat SA, CorWave SA, Leviticus Cardio Ltd., LivaNova PLC, MicroMed Cardiovascular Inc., Novacor SA, Thoratec Corporation, Ventracor Limited

Global Cardiac Assist Devices And Equipment Market Trends and Insights

Major companies operating in the cardiac assist devices and equipment market are focusing on developing miniaturized interventional ventricular assist devices (VADs), such as foldable percutaneous VAD systems, to provide less-invasive circulatory support during high-risk percutaneous coronary interventions and acute cardiogenic shock. A foldable percutaneous VAD system is a catheter-delivered mechanical circulatory-support device designed to be inserted through a small arterial sheath (reducing vascular access size), provide rapid left-ventricular unloading with clinically meaningful flow rates, and lower procedural trauma compared with larger surgical pumps. For instance, in September 2023, magAssist, a China-based developer of circulatory-support devices, introduced the NyokAssist interventional ventricular assist device, which received U.S. FDA Breakthrough Device designation and completed first-in-human use. It is a small-bore (≈9 Fr) foldable catheter pump with an external motor to reduce hemolysis risk, is designed for easy delivery across the aortic arch, and achieved >3 L/min average flow during reported first-in-human high-risk PCI support.

What Are Latest Mergers And Acquisitions In The Cardiac Assist Devices And Equipment Market?

In June 2023, Translumina, a Germany-based interventional cardiovascular device manufacturer, acquired Blue Medical Devices for an undisclosed amount. As a result of the acquisition, Translumina will gain access to Blue Medical’s drug application technology, which ensures zero drug loss during device delivery and delivers a high drug concentration precisely at the target site. The deal also allows Translumina to integrate this patented technology into its wider portfolio, including peripheral and neurovascular intervention products. Blue Medical Devices is a Netherlands-based company specializing in cardiac assist devices and equipment.

Regional Outlook

North America was the largest region in global cardiac assist devices and equipment market in 2025. Western Europe was the second-largest region in cardiac assist devices and equipment market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Cardiac Assist Devices And Equipment Market?

The cardiac assist devices and equipment market consist of sales of ventricular assist devices (LVAD), intra-aortic balloon pumps, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.